Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Leda Bassit, Franck Amblard, Dharmeshkumar Patel, Nicolas Biteau, Zhe Chen, Mahesh Kasthuri, Shaoman Zhou & Raymond F. Schinazi. (2023) The premise of capsid assembly modulators towards eliminating HBV persistence. Expert Opinion on Drug Discovery 18:9, pages 1031-1041.
Read now
Read now
Articles from other publishers (15)
Fenglan Sun, Wei Xia & Yaoling Ouyang. (2023)
Research progress on detection methods for hepatitis B virus covalently closed circular
DNA
. Journal of Viral Hepatitis 30:5, pages 366-373.
Crossref
Crossref
Ming-Ling Chang & Yun-Fan Liaw. (2023) Emerging Therapies for Chronic Hepatitis B and the Potential for a Functional Cure. Drugs 83:5, pages 367-388.
Crossref
Crossref
Lucile Dumolard, Caroline Aspord, Patrice N. Marche & Zuzana Macek Jilkova. (2023) Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation. Frontiers in Immunology 14.
Crossref
Crossref
Geoffrey Dusheiko, Kosh AgarwalMala K. Maini. (2023) New Approaches to Chronic Hepatitis B. New England Journal of Medicine 388:1, pages 55-69.
Crossref
Crossref
Daniel G. Sausen, Oren Shechter, William Bietsch, Zhenzhen Shi, Samantha M. Miller, Elisa S. Gallo, Harel Dahari & Ronen Borenstein. (2022) Hepatitis B and Hepatitis D Viruses: A Comprehensive Update with an Immunological Focus. International Journal of Molecular Sciences 23:24, pages 15973.
Crossref
Crossref
Gustaf E Rydell, Kasthuri Prakash, Simon B Larsson, Catarina Skoglund, Johan Ringlander, Maria E Andersson, Maria Castedal, Heléne Norder & Magnus Lindh. (2022) Quantification of Viral RNA in Multiple Pieces of Explant Liver Tissue Shows Distinct Focal Differences in Hepatitis B Infection. The Journal of Infectious Diseases 226:6, pages 1036-1040.
Crossref
Crossref
Andrew Vaillant. (2022) Oligonucleotide-Based Therapies for Chronic HBV Infection: A Primer on Biochemistry, Mechanisms and Antiviral Effects. Viruses 14:9, pages 2052.
Crossref
Crossref
Thomas Tu, Florian van Bömmel & Thomas Berg. (2022) Surrogate Markers for Hepatitis B Virus Covalently Closed Circular DNA. Seminars in Liver Disease 42:03, pages 327-340.
Crossref
Crossref
Ridhwaanah Jacobs, Prashika Singh, Tiffany Smith, Patrick Arbuthnot & Mohube Betty Maepa. (2022) Prospects of viral vector-mediated delivery of sequences encoding anti-HBV designer endonucleases. Gene Therapy.
Crossref
Crossref
Bushra Tahreem, Ghadir Ali, Haroon Ahmad, Asim Shahzad, Muhammad Khurram, Nabiha Naeem, Aquib Nazar, Muhammad Haris, Hassan .Shahrukh .. (2022) Genotypes Variation and Molecular Epidemiology Of The Hbv Chronic Liver Infection In The Local Population Of Pakistan: An Overview Of The Recent Literature. Pakistan BioMedical Journal.
Crossref
Crossref
Yan-jie Lin, Fang-fang SunZhan ZengXiao-yue BiLiu YangMing-hui Li & Yao Xie. (2022) Combination and Intermittent Therapy Based on Pegylated Interferon Alfa-2a for Chronic Hepatitis B with Nucleoside (Nucleotide) Analog-Experienced Resulting in Hepatitis B Surface Antigen Clearance: A Case Report. Viral Immunology 35:1, pages 71-75.
Crossref
Crossref
Xiaoqin Lv, Xia Xiang, Yue Wu, Yang Liu, Ruqing Xu, Qin Xiang & Guoqi Lai. (2021) GATA binding protein 4 promotes the expression and transcription of hepatitis B virus by facilitating hepatocyte nuclear factor 4 alpha in vitro. Virology Journal 18:1.
Crossref
Crossref
Ranjit Chauhan, Qilan Li, Molly E. Woodson, Makafui Gasonoo, Marvin J. Meyers & John E. Tavis. (2021) Efficient Inhibition of Hepatitis B Virus (HBV) Replication and cccDNA Formation by HBV Ribonuclease H Inhibitors during Infection. Antimicrobial Agents and Chemotherapy 65:12.
Crossref
Crossref
Suchandrima Ghosh, Anannya Chakraborty & Soma Banerjee. (2021) Persistence of Hepatitis B Virus Infection: A Multi-Faceted Player for Hepatocarcinogenesis. Frontiers in Microbiology 12.
Crossref
Crossref
Maura Dandri, Antonio Bertoletti & Marc Lütgehetmann. (2021) Innate immunity in hepatitis B and D virus infection: consequences for viral persistence, inflammation, and T cell recognition. Seminars in Immunopathology 43:4, pages 535-548.
Crossref
Crossref